Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023
- Sunday, June 25, 2023, 7:14
- PR Newswire
- Add a comment
Late-breaking data from BRII-835 + PEG-IFN-a study demonstrate anti-HBs titers at the end of treatment were associated with sustained HBsAg loss 24 weeks after the end of treatment New data show more robust and persistent anti-HBs titers following vaccination with VBI’s 3-antigen…
About the Author
admin has written 21636 stories on this site.